Novartis is pioneering the use of the NIHR’s Associate PI Scheme in commercial trials—delivering faster site setups, improved patient recruitment, and stronger research capacity across the UK. Discover how this collaborative approach is accelerating trial delivery and why it could shape the future of UK clinical research. Read the full story by following the link below.